Clinical Trials Directory

Trials / Completed

CompletedNCT06603090

Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season

Text4Vax: Understanding the Effectiveness and Implementation of Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-2025 Season

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66,147 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
6 Months – 17 Years
Healthy volunteers
Not accepted

Summary

This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Detailed description

The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care). Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.

Conditions

Interventions

TypeNameDescription
BEHAVIORALText message influenza vaccine remindersText message influenza vaccine reminders
BEHAVIORALText message COVID-19 vaccine remindersText message COVID-19 vaccine reminders
BEHAVIORALText message influenza and COVID-19 vaccine remindersText message influenza and COVID-19 vaccine reminders

Timeline

Start date
2024-10-02
Primary completion
2024-12-31
Completion
2025-04-30
First posted
2024-09-19
Last updated
2025-07-11

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06603090. Inclusion in this directory is not an endorsement.